STZ
53
-4
RHI
39
2
AVGO
40
-14
NRG
39
-6
MKC
39
-2
CF
59
2
VTR
46
-4
WBA
15
-14
TSCO
58
3
HPE
59
13
ESS
45
-3
DE
58
-7
AKAM
62
12
ORCL
58
2
SIG
61
6
PFE
37
4
XRX
48
7
ALL
54
3
COF
43
3
MNST
62
-3
STZ
53
-4
RHI
39
2
AVGO
40
-14
NRG
39
-6
MKC
39
-2
CF
59
2
VTR
46
-4
WBA
15
-14
TSCO
58
3
HPE
59
13
ESS
45
-3
DE
58
-7
AKAM
62
12
ORCL
58
2
SIG
61
6
PFE
37
4
XRX
48
7
ALL
54
3
COF
43
3
MNST
62
-3
Financhill
Back

Relay Therapeutics Stock Predictions

This A.I. system is like having 100k financial analysts on hand

Get here to get the full story
Buy
58

RLAY
Relay Therapeutics

Last Price:
11.01
Seasonality Move:
8.05%

7 Day Trial

ALL ACCESS PASS

$ 7

Take advantage of the biggest IPO in history

Click here to see more

Relay Therapeutics Stock Forecast

  • Over the next 52 weeks, Relay Therapeutics has on average historically fallen by 31.2% based on the past 3 years of stock performance.
  • Relay Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%
  • Is Relay Therapeutics Stock Undervalued?
    The current Relay Therapeutics [RLAY] share price is $11.03. The Score for RLAY is 58, which is 16% above its historic median score of 50, and infers lower risk than normal.
  • RLAY is currently trading in the 50-60% percentile range relative to its historical Stock Score levels.

Will Relay Therapeutics Stock Go Up Next Year?

  • Over the next 52 weeks, Relay Therapeutics has on average historically fallen by 31.2% based on the past 3 years of stock performance.

Relay Therapeutics Stock Rating

Buy
58
Relay Therapeutics (RLAY) is a Buy

Is Relay Therapeutics overpriced?

  • Relay Therapeutics has fallen lower in 3 of those 3 years over the subsequent 52-week period, corresponding to a historical accuracy of 100%

Relay Therapeutics Stock Price History

Is RLAY stock going to rise?

  • The current trend is relatively stagnant and RLAY is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Healthcare
Type:
stock
Website:
relaytx.com

52-Week Data

52-Week High:
33.06
52-Week Low:
9.67

Prediction Charts

Market Cap:
1.35B
Price in USD:
11.03
Volume:
1.52M
Beta:
1.38

Technical Analysis

SMA50:
11.55
SMA100:
11.68
SMA200:
14.67
52-Wk Change:
-55.7%

Stock Predictions

  • Is Relay Therapeutics stock public?
    Yes, Relay Therapeutics is a publicly traded company.
  • What is the Relay Therapeutics stock quote today?
    The Relay Therapeutics stock price is 11.03 USD today.
  • How to buy Relay Therapeutics stock online?
    You can buy Relay Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Aug-15 10.88 10.62 11.11 10.50
Aug-16 10.59 10.44 10.79 10.40
Aug-17 10.41 10.35 10.48 10.25
Aug-18 10.23 10.59 10.73 10.20
Aug-21 10.55 10.67 10.86 10.41
Aug-22 10.74 10.57 11.02 10.45
Aug-23 10.62 10.68 11.02 10.62
Aug-24 10.82 9.91 10.82 9.86
Aug-25 9.92 10.27 10.40 9.83
Aug-28 10.33 10.39 10.54 10.28
Aug-29 10.40 10.67 10.75 10.30
Aug-30 10.64 10.64 10.78 10.50
Aug-31 10.63 10.22 10.79 10.21
Sep-1 10.33 11.03 11.06 10.33

Relay Therapeutics Earnings

Relay Therapeutics Earnings Report: Per Share Relay Therapeutics Earnings Q1 Q2 Q3 and Q4 last year and next year.

Relay Therapeutics Forecast Revenue Growth

Relay Therapeutics Stock Analysis: Historical quarterly revenues per share for Relay Therapeutics and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.27 per share, a decrease next quarter of $0.04 per share, a decrease this year of $0.55 per share, and a decrease next year of $0.14 per share.

* Relay Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.